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A B S T R A C T
ROS are frequently associated with deleterious effects caused by oxidative stress. Despite the harmful effects of
non-specific oxidation, ROS also function as signal transduction molecules that regulate various biological
processes, including stem cell proliferation and differentiation. Here we show that mitochondrial ROS level
determines cell fate during differentiation of the pluripotent stem cell line P19. As stem cells in general, P19 cells
are characterized by a low respiration activity, accompanied by a low level of ROS formation. Nevertheless, we
found that P19 cells contain fully assembled mitochondrial electron transport chain supercomplexes (respira-
somes), suggesting that low respiration activity may serve as a protective mechanism against ROS. Upon ele-
vated mitochondrial ROS formation, the proliferative potential of P19 cells is decreased due to longer S phase of
the cell cycle. Our data show that besides being harmful, mitochondrial ROS production regulates the differ-
entiation potential of P19 cells: elevated mitochondrial ROS level favours trophoblast differentiation, whereas
preventing neuron differentiation. Therefore, our results suggest that mitochondrial ROS level serves as an
important factor that directs differentiation towards certain cell types while preventing others.
Key resource table
Reagent or resource Source Identifier
Antibodies
Anti-CK8 Abcam EP1628Y
Anti-Oct4 Santa Cruz Biotech sc-5279
Anti-β-III-Tubulin Santa Cruz Biotech sc-80005
Anti-β-Actin Sigma-Aldrich A5441
Anti-Sod2 Abcam ab13533
Native WB Antibody Cocktail (1:250) that contains antibodies against CI-
NDUFA9 (ab14713), CII-70 kDa subunit (ab14715), CIII-core protein 2
(ab14745), CIV-subunit IV (ab14744) and CV-a subunit (ab14748).
Abcam ab110412
Mouse HRP Linked GE Healthcare NXA931
Rabbit HRP Linked Agrisera AS09602
Mouse/Rabbit Alexa Fluor 488 conjugated Thermofisher Scientific A-11029/A-11034
Experimental Models: Cell Lines
P19 mouse embryonic carcinoma cell line European Collection of
Authenticated Cell Cultures
ECACC 95102107
Chemicals
Rotenone Sigma Aldrich R8875
Potassium cyanide Millipore 1.04965 EMD
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Antimycin Sigma Aldrich A8674
Myxothiazol Sigma Aldrich T5580
Paraquat Sigma Aldrich 856177
RIPA buffer Abcam ab156034
NucBlue Fixed Cell ReadyProbes Reagent Thermofisher Scientific R37606
RNase Cocktail Thermofisher Scientific AM2286
Critical Commercial Assays
ADP/ATP Ratio Assay Kit Sigma Aldrich MAK135
Mitochondria Isolation Kit for Cultured Cells Abcam ab110170
Rnase-free DNase set Qiagen 79254
RNeasy mini kit Qiagen 74104
DC protein assay kit BioRad 500111
ECLPlus Detection Kit GE Healthcare RPN2133
A High Molecular Weight Calibration kit GE Healthcare 17-0445-01
A High Molecular Weight Calibration kit Mouse 8x60K chip Agilent Genomics 074809
Deposited Data
Raw microarray data This paper https://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=
GSE107414
1. Introduction
Reactive oxygen species (ROS), products of one-electron reduction of
molecular oxygen, possess a high oxidative potential and can cause se-
vere damage in living cells. A high ROS level is frequently associated
with oxidative stress. ROS-dependent oxidation of lipids, DNA, and
proteins leads to the accumulation of damaged molecules with impaired
functions (Magder, 2006) eventually resulting in pathologies such as
neurodegenerative diseases (Lin and Beal, 2006), cancer (Liou and
Storz, 2010), and aging (Hekimi et al., 2011).
ROS generation in cells is tightly connected with the oxidative
phosphorylation metabolic pathway (cellular respiration). During this
process electrons flow through four mitochondrial electron transport
chain (mETC) enzymatic complexes and two mobile carriers to the final
acceptor – oxygen. This process releases energy that is used to form the
proton gradient across the mitochondrial inner membrane to produce
ATP (Mitchell and Yochim, 1968). mETC complexes are not freely
floating in the inner membrane, but associated with each other forming
supercomplex structures (Vartak et al., 2013), which provide the op-
timal conditions for electron flow (Gómez et al., 2009). However,
electrons can leak from complex I or complex III, resulting in premature
one-electron oxygen reduction and therefore ROS formation (Murphy,
2009). Thus, mETC is not only the most efficient energy production
source but also one of the main sources of ROS (Adam-Vizi and
Chinopoulos, 2006; Bleier and Dröse, 2013).
Many studies demonstrate that mitochondrial oxidative metabolism
plays a critical role in stem cell maintenance and differentiation. Both
mouse and human pluripotent stem cells are characterized by a rela-
tively low mitochondrial mass, low respiration rate and high glycolytic
activity (Xu et al., 2013). During differentiation, the mitochondrial
oxidative metabolism is activated, resulting in increased cellular re-
spiration and ROS production (Chen et al., 2008; Chung et al., 2007;
Lonergan et al., 2006). Previous studies have indicated that this meta-
bolic switch is not just an adaptation for new functions of differentiated
cells, but mETC activity is an important prerequisite for successful dif-
ferentiation (Rochard et al., 2000; Schieke et al., 2008; Wagatsuma and
Sakuma, 2013; Zhang et al., 2013).
Despite the harmful effects caused by non-specific oxidation, ROS
function as signal transduction molecules in various cell types, including
stem cells (Holmström and Finkel, 2014). Some studies suggest that ROS
signaling regulates stem cell proliferation and differentiation. For ex-
ample, increased ROS levels due to deletion of AMT kinase (Ito et al.,
2004) or FOXO transcriptional factors (Miyamoto et al., 2007; Tothova
et al., 2007) impair hematopoietic stem cells proliferation. While these
results indicate that increased ROS level impairs stem cell proliferation,
a decreased ROS level also has negative effects. For example, neural
stem cells (Le Belle et al., 2011), as well as spermatogonia stem cells
(Morimoto et al., 2013) require physiological ROS level for self-renewal.
Moreover, ROS production is critical for at least some types of differ-
entiation. For instance, mitochondrial ROS production is necessary for
adipocyte (Tormos et al., 2012) and muscle (Lee et al., 2011) differ-
entiation.
Here we show that increased mitochondrial ROS production influ-
ences both proliferation and differentiation of pluripotent P19 cells.
High mitochondrial ROS level reduces the cell proliferation rate due to
the S phase elongation and also influences cell fate during differentia-
tion: it favours trophoblast differentiation but prevents neuron differ-
entiation. Our findings suggest that mitochondrial ROS level serves as
an important factor that directs differentiation towards certain cell
types, whereas preventing others.
2. Materials and methods
2.1. Cell culture and differentiation
Cells were cultured in DMEM medium supplied with 10% FBS at
37 °C, 5% CO2. Cells were passaged every 48 h and plated at a density of
2*104 cells/cm2. The medium was changed every day. mETC inhibitors
were added to the medium in the following concentrations: 0.1 μM ro-
tenone, 0.25 μM antimycin A, 5 nM myxothiazol, and 25 μM potassium
cyanide. Paraquat was added in a final concentration of 100 μM. To
induce trophoblast differentiation, P19 cells were plated at a density
0.52*104 cells/cm2 and grown as a monolayer with 1 μM retinoic acid
(RA) for 4 days. To induce neuron differentiation, 8.32*106 cells were
plated in 10 cm culture dish covered with 1% agarose. Cells grown in
suspension with 1 μM RA formed embryoid bodies (EBs). The EBs were
grown for 4 days, trypsinized to disaggregate cells, and grown as a cell
monolayer at a density 3.6*104 cells/cm2 with 1 μM RA for 4 days.
2.2. Immunocytochemistry
Cells were fixed in 10% Neutral Buffered Formalin (NBF) solution for
30min at room temperature (RT) and permeabilized for 10min in
0.25% Triton X-100. Then samples were blocked in 10% normal goat
serum for 1 h at RT. After blocking, samples were incubated with pri-
mary antibodies against CK8 (1:150), Oct4 (1:100), or β-III-tub (1:100)
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in 1.5% normal goat serum overnight at 4 °C and then with secondary
Alexa Fluor 488 conjugated antibodies (1:500) 30min at RT. Nuclei
were stained with 1 μg/ml Hoechst 33342 for 20min. Cells were im-
aged with the fluorescent microscope (Axio Observer Z1, Zeiss). Each
experiment was repeated at least three times.
To analyse the number of CK8+ in the differentiated cell popula-
tion, 3*106 cells were fixed in 4% NBF for 10min and permeabilized for
30min with ice-cold methanol. Then samples were incubated with CK8
antibodies (1:100) in 0.5% BSA in PBS for 1 h at RT and with secondary
antibodies (1:500) for 1 h at RT. Cell suspensions were used for flow
cytometry analysis (CyFlow Class 1, Partec). CK8+ was gated using the
Flow Max software (Partec) and the mean proportions of CK8+ cells in
differentiated populations from three independent experiments were
compared using the unpaired two-tailed t-test.
2.3. Oxygen consumption measurements
Oxygen consumption rate was measured polarographically using a
Clark electrode (Strathkelvin Instruments) as previously described
(Barrientos et al., 2009). The medium was refreshed 4 h before mea-
surements. Cells were collected, counted and resuspended in respiration
buffer (0.3M mannitol, 10mM KCl, 5 mM MgCl2, and 10mM K2PO4,
pH 7.4). The 782 Oxygen System software (Strathkelvin Instruments)
was used to calculate oxygen consumption rates, which were normal-
ized to the number of cells used for the analysis. Mean oxygen con-
sumption rates from three independent experiments were compared
using the unpaired two-tailed t-test.
2.4. MitoSox staining
Cells were plated and grown for 24 h. Then cells were loaded with
1 μM MitoSox for 15min and afterwards grown for 12 h with mETC
inhibitors or paraquat; the MitoSox fluorescence signal was analysed by
flow cytometry (Flow Max CyFlow Class 1, Partec). The mean fluor-
escent intensity (MFI) of the treated cell population was normalized to
MFI of untreated cells. Mean MFIs from four independent experiments
were compared using the one sample t-test.
2.5. ATP/ADP level measurement
Trophoblast differentiated cells were incubated with mETC in-
hibitors for 24 h. After that, ATP and ADP concentrations were mea-
sured with ATP/ADP ratio bioluminescent assay kit according to the
manufacturer's manual. Mean ATP/ADP ratios from four independent
experiments were compared using the unpaired two-tailed t-test.
2.6. Western blot analysis
Cells were lysed in RIPA buffer and then centrifuged at 11,000×g
for 20min at 4 °C. 50 μg of total protein lysate was loaded, separated
and blotted. For immunostaining, membranes were blocked in 5% milk
in TBS-T for 1 h at RT and then were incubated overnight at 4 °C with
5% milk in TBS-T containing primary antibodies CK8 (1:20000), β-III-
tub (1:1000), β-act (1: 5000), Oct4 (1:1000), or Sod2 (1:5000) and
afterwards secondary anti-mouse (1:5000) or anti-rabbit (1:10000)
antibodies for 30min at RT. The HRP signal was detected with the
G:Box (Syngene). To quantify Sod2 level the signal was evaluated by
the software GeneTools (Syngene) as an optical density (OD) using the
rolling disk method for background subtraction and correction. The
Sod2 signal was corrected to the β-act and quantified as a fold change of
the OD in treated cells to the control. Each experiment was repeated at
least three times.
2.7. BN-page
BN-PAGE was performed as previously described (Schaegger, 2001).
In brief, 200 μg of mitochondria isolated and lysed in buffer containing
digitonin to a protein ratio 4:1 as detergent and loaded to 3–13%
polyacrylamide gradient gels.
To visualise active CI, gels were equilibrated in buffer I (2 mM Tris/
HCl pH 7.4) for 1 h at RT and incubated in buffer I with 0.1mg/ml
NADH and 2.5mg/ml nitro blue tetrazolium until purple bands ap-
peared. For CIV in-gel staining, gels were equilibrated in buffer IV-1
(270mM glycine/tris; 14mM MgCl2; pH 8.4) for at least 2 h at RT and
then revealed in buffer IV-2 (50mM KPPi; 75 mg/ml sucrose; 1 mg/ml
diaminobenzidine; 0.5mg/ml reduced cytochrome c; pH 7.4).
For the second dimension SDS-PAGE, gel lanes from BN gels were
placed on top of a 12% separating polyacrylamide gel containing 0.25%
SDS. After separation and blotting, membranes were probed with the
total OXPHOS Blue Native WB Antibody Cocktail (1:250).
2.8. Cell population doubling time analysis
19.2*104 cells were plated in 6-well plates. Cells were grown with
mETC inhibitors or paraquat for 16–18 h. Then, based on the number of
cells collected from plates, cell doubling time was calculated. Mean cell
population doubling times from four independent experiments were
compared using the unpaired two-tailed t-test.
2.9. Cell cycle analysis
Cell cycle profile was analysed based on the DNA content. Cells
were grown for 12 h with mETC inhibitors or paraquat. Then 106 cells
were fixed with ice-cold ethanol for 2 h at 4 °C, washed with PBS and
resuspended in the staining solution (0.1% v/v Triton X-100, 10 μg/ml.
propidium iodide, 5 μl/ml RNase Cocktail in PBS). Cells were in-
cubated for 30min at 37 °C and then propidium iodide fluorescence was
measured with flow cytometry (BD LSR II, BD Bioscience). Cell cycle
profiles were analysed using the FlowJo software (FlowJo, LLC). The
mean proportion of cells in G1, S and G2/M phases from five in-
dependent experiments were compared using the unpaired two-tailed t-
test.
2.10. Microarray analysis
mRNA was extracted from cells incubated for 12 h with myxothiazol
(three independent samples) as well as from control cells (four in-
dependent samples), transcribed to cDNA, labelled and hybridized on a
Mouse 8x60K chip. Microarray data were analysed with the GeneSpring
software (Agilent Genomics). To reduce false-positive expression
changes, background correction with 20th percentile cut-off was per-
formed. Expression rates in myxothiazol treated samples were com-
pared to the control samples to reveal fold-changes of gene expression
using the unpaired t-test with Benjamini-Hochberg corrections. All
statistically significant expression changes that were lower 1.5 were
considered biologically not significant and thus cut off. The gene ex-
pression profile of myxothiazol treated cells was analysed with the
Ingenuity Pathway Analysis (IPA, Qiagen) software core analysis tool.
The microarray data are available at the Gene Expression Omnibus
database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE107414).
2.11. Statistical analysis
All results are presented in the text as mean ± standard error of the
mean. On plots data are presented as median, 25th and 75th and per-
centile (box) and minimum/maximum values (whiskers). Data were
analysed using Student's t-test. A P-value of< 0.05 was considered
statistically significant.
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2.12. Key resources table
The Key Resources Table provides the essential data about anti-
bodies and commercial assays used in the work.
3. Results
3.1. Cellular respiration is activated during the differentiation of P19 cells
P19 is a murine embryonal carcinoma pluripotent cell line that
possesses main criteria of embryonic stem cells (ESCs) (McBurney and
Fig. 1. Differentiation of P19 cells is associated with activation of cellular respiration.
a. P19 cells morphology. Fluorescent and differential interference contrast (DIC) images of P19 cells; cells are stained with antibodies against the pluripotency factor
Oct4 (green). Nuclei are stained with Hoechst (blue). 40× magnification, the scale is 20 μm. b. Trophoblast morphology of differentiated cells. Fluorescent images of
differentiated cells; cells are stained with antibodies against differentiation markers cytokeratin 8 (CK8) and β-III-tubulin (β-III-tub) (green). Nuclei are stained with
Hoechst (blue). 40× magnification, the scale is 20 μm. c. Neuron morphology of differentiated cells. Phase-contrast image of embryoid bodies (left);10× magni-
fication, the scale is 200 μm. Fluorescent image of neuron-like differentiated cells (right); cells are stained with antibodies against the differentiation marker β-III-tub
(green); nuclei are stained with Hoechst (blue); 10× magnification, the scale is 200 μm. d. Western blot analysis of the pluripotency marker Oct4 expression and
differentiation markers CK8 and β-III-tub in not differentiated P19 cells and their trophoblast (Tr) and neuron (Neu) differentiated derivatives; β-actin (β-act),
Ponceau S (PS) and Coomassie Blue (CB) stainings are used as a loading controls. e. Oxygen consumption rate displayed as nM of oxygen consumed by 106 of cells in
1 min, n=3. The mean oxygen consumption rates of trophoblast (Tr) and neural (Neu) differentiated cells were compared to not differentiated (ND) with the
unpaired two-tailed t-test; *** p-value≤ .005, **** p-value≤ .001. f. MitoSox fluorescent signal displayed as a fold change of mean fluorescence intensity (MFI) of
trophoblast (Tr) and neural (Neu) differentiated cells compared to undifferentiated P19 cells, n= 3; dashed line represents the level of MitoSox signal in un-
differentiated P19 cells. The mean MFIs fold changes were compared using the one sample t-test; * p-value≤ .05.
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Rogers, 1982). P19 cells are round-shaped with a high nuclear to cy-
toplasm ratio that express the main pluripotency markers Oct4, Sox2
and Nanog (Vega-Naredo et al., 2014). We used Oct4 as a marker of
pluripotent state of cells. (Fig. 1 a, d). Like ESCs, P19 cells differentiate
in response to retinoic acid (RA) yielding various types of differentiated
cells depending on growth conditions. Upon addition of RA to a cell
monolayer cells differentiated to trophoblast-like cells that express cy-
tokeratin 8 (CK8) (Fig. 1 b, d) (Jones-Villeneuve et al., 1982; Vega-
Naredo et al., 2014). Moreover, some differentiated cells expressed a
higher amount of β-III-tubulin protein that is commonly used as an
early neuron marker (Fig. 1 b, d). The respective cells, however, did not
demonstrate a neuron morphology (Fig. 1 b). Under a slightly modified
differentiation protocol, P19 cells give rise to neuron-like cells (Jones-
Villeneuve et al., 1983). To induce this neuron differentiation, P19 cells
in suspension were grown with RA to form 3D embryoid bodies (Fig. 1
c). Upon plating as a monolayer, the cells gained the neuron-like
morphology and expressed the neuron differentiation marker β-III-tu-
bulin (Fig. 1 c, d). The resemblance to ESCs and the robust differ-
entiation make P19 cells a good model to study stem cell differentiation
(Bain et al., 1994).
As stem cells in general, P19 cells rely on glycolysis for energy
production (Vega-Naredo et al., 2014). To test whether P19 cells show
an activation of the oxidative metabolism during differentiation, we
followed the cellular oxygen consumption rate during trophoblast and
neuron differentiation. Both trophoblast and neuron differentiated cells
were characterized by an increased oxygen consumption
(3.8 ± 0.35 nM and 3.7 ± 0.24 nM O2/1min*106 cells, respectively)
compared to undifferentiated cells (1.17 ± 0.08 nM O2/1min*106
cells) (Fig. 1 e). Increased respiration is frequently accompanied by
increased ROS production due to electron leakage from mETC. To test
mitochondrial ROS level during differentiation we used the mitochon-
drial ROS-sensitive fluorescent dye MitoSox (see Supplementary Fig. 1).
Both trophoblast and neuron differentiated cells showed a significant
increase in the mean intensity of MitoSox fluorescence (1.75 ± 0.17
and 1.46 ± 0.11-fold increase, respectively) (Fig. 1 f). Increased
oxygen consumption and ROS production show the activation of mETC
activity during differentiation of P19 cells.
3.2. P19 cells contain a mature mETC machinery that is activated during
differentiation
mETC activity in P19 cells is lower than in their differentiated de-
rivatives. The low respiration rate could be explained by inefficient
mETC machinery assembly in pluripotent cells. To analyse the mETC
composition, mitochondria from undifferentiated P19 cells, embryoid
bodies, trophoblast, and neuron differentiated cells were separated on a
Blue Native (BN) PAGE. Part of the gel was stained for complex I (CI)
and IV (CIV) activity (Fig. 2 a), while the remaining gel was used for a
subsequent SDS-PAGE to reveal the subunit composition of mETC
(Fig. 2 b).
The in-gel staining showed no changes in CI and CIV activity upon
differentiation (Fig. 2 a). The active CI is visible as a band at a mole-
cular weight of around 1MDa in all samples. Besides a monomeric form
of CI, there are also bands of higher molecular weight corresponding to
the active CI in supercomplex structures (C, D, E). The active CIV is
visible as a band with the molecular weight of around 440 kDa (Fig. 2 a)
corresponding to the dimeric form of CIV (CIV2) (Krause et al., 2005).
Additional bands of higher molecular weight correspond to CIV in-
cluded in supercomplex structures (A, B, E).
Under the reducing and denaturing conditions of 2D-SDS-PAGE, the
complexes and supercomplexes were dissociated into their subunits and
analysed by immunostaining with an antibody cocktail containing an-
tibodies against one core subunit for each of mETC complexes. In
general, the mETC structures are very similar in undifferentiated P19
cells and differentiated derivatives. CI was present in its monomeric
form and in supercomplexes C, D, and E (Fig. 2 b). CIV was detected as
a dimer (CIV2) and as part of A, B, and E supercomplexes. ATP-synthase
was detected as two signals, reflecting its mono- and dimeric form.
Complex II (CII) was slightly different in differentiated cells compared
to P19 cells: in addition to a monomeric form undifferentiated P19 cells
contained a CII signal in a lower molecular weight range probably
corresponding to only partially assembled CII. The structure of Complex
III (CIII) also differed between P19 cells and differentiated derivatives.
Although CIII was equally present in supercomplexes (A, B, C, D, and E)
in differentiated and undifferentiated cells, the CIII dimer (CIII2) could
only be detected in P19 cells, but not in differentiated cells (Fig. 2 b, red
arrow). The exclusive detection of the dimeric form of CIII in P19 cells
suggests that assembly of supercomplexes in P19 cells may be less ef-
ficient than in the differentiated derivatives.
Supercomplexes' compositions (Fig. 2 c), based on in-gel activity
stainings, were identical to the previously described active super-
complexes extracted from bovine heart (Schäfer et al., 2006). Im-
portantly, supercomplexes D and E correspond to active respirasome
(Vartak et al., 2013), indicating that P19 cells despite their low re-
spiration (Fig. 1 e) contain a functional mETC machinery. Therefore,
the regulation of mETC activity and ROS production may influence
stem cell maintenance and/or differentiation potential.
3.3. mETC inhibitors and paraquat induce ROS production in P19 cells
Low activity of mitochondrial oxidative metabolism in stem cells
may serve as a mechanism that protects cells against ROS. To test the
impact of mitochondrial ROS produced by mETC on stem cells, we used
chemical inhibitors of CI (rotenone) and CIII (antimycin A and myx-
othiazol) that enhance ROS production specifically in mitochondria.
These mETC inhibitors prevent electron flow and increase the rate of
electron leakage from mETC, resulting in increased ROS production
(Fig. 3 a) (Brand, 2010; Kramer et al., 2003; Starkov and Fiskum, 2001).
Rotenone, antimycin A, and myxothiazol are structurally unrelated
pharmacological agents and therefore unlikely cause the same side ef-
fects in cells. Potassium cyanide, that blocks the electron flow at the
level of CIV when the electron energy is too low to induce ROS pro-
duction, was used as a negative control (Murphy, 2009). We also used
paraquat as a ROS inducing agent. It accumulates in mitochondria
(Castello et al., 2007), easily accepts electrons from different sources
and transfers them to oxygen resulting in superoxide formation (Krall
et al., 1988).
As mETC activity can influence ATP level, we investigated how
mETC inhibitors alter the energetic state of cells. Due to the low level of
respiration in undifferentiated P19 cells (Fig. 1 e, f), we used tropho-
blast differentiated cells with active respiration for this experiment. We
measured the ATP/ADP ratio in differentiated cells exposed to mETC
inhibitors for 24 h. Due to the low mETC inhibitors' concentrations used
in experiments, none of them led to any significant change of the ATP/
ADP ratio (Fig. 3 b).
We next monitored how mETC inhibitors and paraquat influence
ROS production of P19 cells. To visualise ROS in mitochondria speci-
fically we used the MitoSox fluorescent probe. As expected, rotenone,
antimycin A, myxothiazol, and paraquat increased the mean fluorescent
intensity of the MitoSox signal compared to the control (Fig. 3 c),
whereas cyanide had no significant effect. As an additional indirect
evidence for increased ROS production, we detected mitochondrial
superoxide dismutase (Sod2) protein level – one of the main enzymes
that protect cells from oxidative stress (Van Remmen et al., 2004). All
mETC inhibitors as well as paraquat increased Sod2 protein level, with
antimycin A and myxothiazol showing the strongest effect (Fig. 3 d).
The increased level of Sod2 caused by potassium cyanide probably is
not associated with ROS level, but caused by side effects of cyanides.
3.4. Mitochondrial ROS level influences cell cycle progression
Previous studies, as well as our results, suggest that ROS level is
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important for stem cell maintenance. To test this hypothesis, we ana-
lysed how increased ROS level influences cell cycle profile of P19.
Firstly, we measured the cell proliferation rate by calculating cell
population doubling time. P19 cells divided every 8.5 h (Fig. 4 a),
corresponding to the division rate of murine ESCs (Abdelalim, 2013).
Rotenone and potassium cyanide slightly slowed down cell division (up
to 10.7 h and 9.5 h respectively), while antimycin A and myxothiazol
significantly decreased cell duplication time (14.4 h and 21 h
respectively). Paraquat also caused an effect that was comparable to
CIII inhibitors, but weaker (13.7 h).
Secondly, we analysed the cell cycle profile by nuclear DNA staining
with the stoichiometric fluorescent dye propidium iodide. The pro-
portion of cells with single (2n), intermediate or double (4n) DNA set
reflects the duration of G1, S, and G2/M phases, respectively.
Undifferentiated P19 cells demonstrated a cell cycle profile typical for
murine ESCs (Abdelalim, 2013) with a long S phase and short G1 and
Fig. 2. P19 cells contain mature respirasomes. a. In-gel activity staining of CI and CIV separated by BN-PAGE. mETC complexes extracted from not differentiated P19
cells (ND), embryoid bodies (EB), trophoblast (Tr) and neuron (Neu) differentiated cells. Purple bands reveal active CI or CI included in supercomplexes. Brown
bands reveal active CIV corresponding to CIV2 or CIV included in supercomplexes. CB staining revealed the most abundant proteins. b. 2D-SDS-PAGE that separated
mETC structures received from P19 cells and trophoblast differentiated cells. The immunostaining reveals CI, CII, CIII2, CIV2, CV, and CV2 as well as supercomplex
structures. The red arrow points to the position where CIII2 should be located. c. The table shows the supercomplexes (SC) compositions based on in-gel activity
stainings and immunostainings. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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G2/M phases (Fig. 4 b). Although rotenone and potassium cyanide
slowed down the cell division rate, they did not change the proportion
of cell phases' duration (Fig. 4 c). Antimycin A, myxothiazol and
paraquat, on the other hand, caused a significant elongation of S phase
and shortened both G1 and G2/M phases. In summary, elevated ROS
decreases the proliferation rate of P19 cells due to elongated S phase.
3.5. Increased ROS level enhances trophoblast and prevents neuron
differentiation
Next, we tested the impact of ROS production on the differentiation
potential by adding mETC inhibitors or paraquat to the medium (Fig. 5
a) during trophoblast differentiation. Antimycin A, myxothiazol, and
paraquat significantly increased the amount of CK8 protein as shown by
Western blot analysis; rotenone had a weaker effect on CK8 expression,
whereas cyanide did not influence CK8 expression. ROS produced by CI
have weaker effects on differentiation most likely due to their locali-
zation in mitochondrial matrix. CIII, on the other hand, releases ROS in
the intermembrane space, resulting in higher ROS mobility.
The increased amount of CK8 protein could be explained by an in-
creased amount of CK8+ cells upon differentiation. To test this, we
performed immunostaining of the cells with further visualisation of the
CK8 signal by flow cytometry. The presence of antimycin A or myx-
othiazol during the differentiation increased the number of CK8+ cells
in the cell population (Fig. 5 b); rotenone and paraquat caused a si-
milar, but weaker effect, whereas cyanide did not change the propor-
tion. This result suggests that the elevated mitochondrial ROS level
favours differentiation by increasing the proportion of trophoblast cells
in the differentiated cell population.
To address the question if ROS level influences exclusively tropho-
blast differentiation, we induced neuron differentiation in the presence
of the same concentrations of mETC inhibitors. Interestingly, paraquat
was lethal for cells during neuron differentiation. As the influence of
paraquat on ROS level is comparable to CI and CIII inhibitors (Fig. 3 c),
the lethality is probably not associated with ROS level, but rather with
side effects of paraquat. The efficiency of neuron differentiation was
estimated by the early neuron marker β-III-tubulin expression shown by
Western blot analysis. Rotenone, antimycin A, and myxothiazol de-
creased the amount of β-III-tubulin compared to the differentiated
control cells (Fig. 5 c). The presence of rotenone significantly decreased
the number of neuron-like cells, while antimycin A and myxothiazol
almost completely prevented neuron differentiation (Fig. 5 d). The in-
hibitors, however, did not prevent differentiation in general because
they drastically increased the amount of CK8 expression (Fig. 5 c).
Apparently, increased mitochondrial ROS level does not generally
prevent differentiation, but rather direct it in certain cell types towards
trophoblast differentiation.
Fig. 3. CI and CIII inhibitors as well as paraquat increase ROS production in P19 cells. a. Schematic illustration showing ROS generation induced by mETC inhibitors.
b. ATP/ADP ratio in cells exposed to mETC inhibitors rotenone (Rot), antimycin A (Ant), myxothiazol (Myx), or potassium cyanide (CN) for 24 h, n=4. The ATP/
ADP ratios of cells exposed to mETC inhibitors were compared to ATP/ADP ratio of not treated cells with the unpaired two-tailed t-test. c. MitoSox fluorescent signal
of P19 cells displayed as a fold change of MFI caused by mETC inhibitors or paraquat (PQ) exposure for 12 h compared to not treated P19 cells, n= 4; dashed line
represents the level of MitoSox signal in not treated cells. Means of MFI fold changes were compared using the one sample t-test; * p-value≤ .05, ** p-value≤ .01,
*** p-value≤ .005, **** p-value≤ .001. d. Western blot analysis of the ROS-defensive enzyme Sod2 in P19 cells exposed to mETC inhibitors or PQ for 24 h; β-act, PS
and CB stainings are used as a loading controls. Numbers show the fold change of means of optical density ± standard error Sod2 expression corrected to β-act
amount in treated cells compared to the control.
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3.6. Myxothiazol changes expression of genes associated with pluripotency,
development and cell cycle progression
Increased ROS level influenced both proliferation and differentia-
tion of P19 cells. To find out how ROS level influences gene expression
in P19 cells we performed a microarray analysis. As myxothiazol
showed the strongest effects, we used it to induce mitochondrial ROS
production. The microarray analysis showed a change in the expression
of 6209 genes by 1.5-fold or more (Fig. 6). Expression profiles of genes
that were altered by myxothiazol treatment were analysed with the
Ingenuity Pathway Analysis (IPA, Qiagen) software core analysis tool
that reveals biological functions and canonical pathways that are most
likely relevant to the input gene list based on the annotated records
contained in the Ingenuity Pathways Knowledge Base.
IPA canonical pathway analysis revealed the strongest association of
myxothiazol with The Transcriptional Regulatory Network in ESCs
(Table 1). Myxothiazol changed the expression level of 24 genes that
regulate transcription in ESCs and their differentiation potential (see
Supplementary Table 1). Firstly, P19 cells exposed to myxothiazol
expressed higher level of Eomes (Russ et al., 2000) and Cdx2 (Niwa
et al., 2005) genes that regulate the formation of the first differentiated
linage of mammalian embryogenesis – trophectoderm. Eomes and Cdx2
upregulation indicates that P19 cells exposed to myxothiazol are more
potent to differentiate in trophectoderm. Secondly, myxothiazol ex-
posure induced the expression of endoderm differentiation regulators
Gata3 (Zhang et al., 2007), Gata4 (Soudais et al., 1995), and Gata6
(Morrisey et al., 1998). Finally, myxothiazol probably influenced ec-
toderm development. For example, the expression of Otx1 (Kurokawa
et al., 2004) and Sox2 (Ferri et al., 2004) that are important for fore-
brain development were downregulated. Moreover, myxothiazol in-
creased the expression of the negative regulator of neurogenesis Isl2
(Thaler et al., 2004). On the other hand, myxothiazol increased the
expression of Lhx5 that stimulates proliferation of neuron stem cells
(Zhao, 1999) and of L1cam that acts as an anti-apoptotic factor during
neuron differentiation (Naus et al., 2004). In summary, myxothiazol
changed the expression of genes associated with early ESCs differ-
entiation, such as trophectoderm formation and dissociation of germ
layers. These results stay in line with our experimental data: the
Fig. 4. Increased ROS production slows down cell cycle progression, predominantly due to the S phase elongation. a. Cell population doubling time of P19 cells
exposed to mETC inhibitors, or PQ, n=4. Mean cell population double times were compared using the unpaired two-tailed t-test; *p-value≤ .05, ** p-value≤ .01,
**** p-value≤ .001. b. Schematic illustration showing the cell cycle in P19 cells, based on propidium iodide staining and DNA amount analysis in the cell population;
the chart shows the mean percentages of cells in G1 (green), S (blue) and G2/M (yellow) phases in dividing P19 cell population, n=5. c. Percentages of cells in G1
(left), S (middle) and G2/M (right) phases after 12 h exposure to mETC inhibitors or PQ, calculated based on the DNA staining with propidium iodide, n= 5. Mean
cell population proportions were compared using the unpaired two-tailed t-test; * p-value≤ .05, *** p-value≤ .005, **** p-value≤ .001. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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expression profile of genes involved in the transcriptional regulation of
ESCs demonstrated that myxothiazol treatment made P19 cells more
potent to differentiate in trophectoderm but not to ectoderm.
In addition, IPA biological function analysis reveals that myx-
othiazol treatment was associated with several types of differentiation,
including epithelial tissue, neurons, adipocytes, muscles, trophoblasts
and endodermal cells, as well with cell proliferation and cell cycle
progression (see Supplementary Table 2).
Fig. 5. mETC inhibitors increase the efficiency of trophoblast differentiation whereas preventing neuron differentiation. a. Western blot analysis of differentiation
marker CK8 and β-III-tub expression in cells differentiated with mETC inhibitors or PQ. β-act, PS and CB stainings are used as a loading controls. b. Percentages of
CK8 positive (CK8+) cells in the population of differentiated cells exposed to mETC inhibitors or PQ during differentiation, n=3. Mean cell population proportions
were compared using the unpaired two-tailed t-test; * p-value≤ .05. c. Western blot analysis of the differentiation marker CK8 and β-III-tub expression in cells
differentiated with mETC inhibitors. β-act PS and CB stainings are used as a loading controls. d. Fluorescence image of cells differentiated with Rot, Ant or Myx
stained with antibodies against β-III tub (green). Nuclei were stained with Hoechst (blue). 10×magnification, the scale is 100 μm.
Fig. 6. Microarray gene expression analysis. Up- (red) and down-regulated
(green) genes in cells exposed to myxothiazol for 12 h. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article.)
Table 1
Top list of Ingenuity Canonical Pathways that are associated with myxothiazol
treatment.
Ingenuity canonical pathway p-value Overlap
Transcriptional regulatory network in ESCs 9.66*10−6 24/46
PPAR signaling 6.73*10−4 34/90
PCP pathway 1.22*10−3 24/59
ErbB2-ErbB3 signaling 2.48*10−3 25/65
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4. Discussion
The presence of highly reactive oxidants such as ROS can be harmful
to cells, due to oxidative damage of biomolecules, including lipids,
protein, and DNA. DNA damage causes accumulation of mutations that
are especially dangerous for long living and fast dividing cell types,
such as stem cells. Although high ROS level decreases the proliferation
potential of stem cells, ROS cannot be regarded as exclusively harmful
for stem cells. Our data show that mitochondrial ROS level directs cell
fate during differentiation.
As stem cells in general, P19 cells are characterized by a low re-
spiration activity (Fig. 1 e) and therefore low ROS production (Fig. 1 f).
However, it was unclear if the low respiration level is caused by an
incomplete mETC. In this work, we show that pluripotent P19 cells
contain assembled respirasomes (Fig. 2) – functional units for cellular
respiration. In our previous study, we also showed that human me-
senchymal stem cells contain assembled supercomplexes, resembling
respirasomes (Hofmann et al., 2012). Despite the presence of respira-
somes, both P19 cells and human mesenchymal stem cells (Chen et al.,
2008) possess a relatively low respiration activity. These results to-
gether indicate that stem cells possess a complete respiration machinery
which is apparently not active hence preventing ROS generation.
To elucidate how increased mitochondrial ROS level influences cell
properties, we used four mETC inhibitors. As expected, the disruption of
the electron flow through mETC CI and CIII increase ROS production
(Fig. 3) (Brand, 2010; Dröse and Brandt, 2008; Kramer et al., 2003).
Effects of mETC inhibitors on ROS level are probably comparable with
the physiological ROS induction that happens due to the cellular re-
spiration activation during differentiation. Our results demonstrate that
trophoblast differentiation and neuron differentiation increase ROS
level by 75% and 51% respectively (Fig. 1 f), while inhibitors by
16–20% (Fig. 3 c). Application of multiple mETC inhibitors provides
several advantages: (1) to discriminate the effects of ROS production
from side effects of each inhibitor; (2) to provide an appropriate ne-
gative control by applying potassium cyanide; (3) to allow monitoring
the effects of ROS production both in mitochondrial matrix from CI
(Dröse and Brandt, 2008) and intermembrane space from CIII (Bleier
and Dröse, 2013). Interestingly, while the CI inhibitor rotenone caused
the strongest effect on the MitoSox signal (Fig. 3 c), it had less effect on
P19 proliferation (Fig. 4) and differentiation (Fig. 5). This may be ex-
plained by the fact that the positively charged MitoSox preferentially
accumulates in the mitochondrial matrix (Forkink et al., 2010) and
therefore is more sensitive to superoxide produced by CI. We used the
expression level of mitochondrial Sod2 as an additional indirect evi-
dence for ROS production level in cells. Indeed, mETC inhibitors in-
creased Sod2 expression (Fig. 3 d), with antimycin A and myxothiazol
showing the strongest induction. Potassium cyanide also induced Sod2
production but did not show any influence on MitoSox staining. This
result can probably be explained by the fact that cyanides block Sod1
activity (Rigo et al., 1975) and cells might compensate reduced Sod1
activity by increased Sod2 expression.
The weaker effect of ROS produced from CI can be also explained by
the mechanism of ROS production. The most probable site of electron
leakage in CI is located in the peripheral arm, resulting in superoxide
formation in the mitochondrial matrix (Dröse and Brandt, 2012). There,
superoxide is quickly degraded by highly potent ROS-defending me-
chanisms (Antunes et al., 2002). That could also explain why the CI
inhibitor rotenone doesn't induce SOD2 expression. CIII, on the other
hand, releases superoxide in the more oxidized milieu (Hu et al., 2008)
of the intermembrane space (Brand, 2010). Therefore, ROS produced by
complex III is stable enough to migrate in the cytoplasm and activate
ROS signaling.
High ROS levels induced by CI and CIII inhibitors or paraquat de-
creased the proliferation potential of P19 cells (Fig. 4). This result stays
in line with previous studies (Ito et al., 2004; Miyamoto et al., 2007;
Tothova et al., 2007). Moreover, increased mitochondrial ROS
generation results in a longer S phase, but a shorter G1 phase (Fig. 4 c).
Similar effects of ROS level on G1 phase were previously shown in
several publications. The presence of thiol-antioxidant NAC causes G1
cell cycle arrest of mouse fibroblasts (Menon et al., 2003; Sekharam
et al., 1998) and rat hepatic stellate cells (Kim et al., 2001). Altogether
these results suggest that ROS level regulate the G1/S phase transition:
decreased ROS level causes G1 arrest, whereas increased ROS level
promotes G1/S transition.
Besides proliferation, ROS level also influences the differentiation
potential of P19 cells. Increased ROS production caused by CI and CIII
inhibitors prevented neuron differentiation (Fig. 5 a, b). At the same
time, increased ROS level enhanced trophoblast differentiation (Fig. 5
c, d). These results also are confirmed by gene expression analysis
showing that the expression of main trophectoderm regulators Eomes
and Cdx2 is enhanced by myxothiazol treatment. Myxothiazol treat-
ment also changed the expression of genes that are involved in neuron
differentiation and development of nervous system (see Supplementary
1 Table 2). Our results stay in line with the previously shown associa-
tion between cell cycle progression and the potential of pluripotent cells
to differentiate in trophoblasts: the absence of G1 cyclins D and E in
mouse embryonic stem cells causes the cell cycle slow down while
enhancing trophoblast differentiation (Liu et al., 2017).
ROS regulation is probably not exclusive for mouse ESCs. Increased
ROS level in human ESCs, for instance, enhances the differentiation of
cells in mesoderm and endoderm lineages (Ji et al., 2010). Induced
pluripotent stem cells (iPSCs) possess mitochondria morphologically
and functionally very similar to ESCs (Armstrong et al., 2010; Prigione
et al., 2010). ROS level participates in the regulation of differentiation
potential of iPSCs. High level of ROS, for example, promotes arterial
endothelial cell specification of mouse iPSCs (Kang et al., 2016). Hence
it will be very interesting to investigate the influence of ROS in human
ESCs and iPSCs in detail in future studies.
Previous studies demonstrated that ROS level could be harmful
(Pereira et al., 2013) or beneficial (Ji et al., 2010; Lee et al., 2011;
Tormos et al., 2012) for differentiation potential of stem cells. Our work
indicates that ROS function is more complex. The ROS level serves as an
additional factor that determines the pathway of differentiation, en-
hancing one, whereas preventing other cell type differentiation. A
better understanding of ROS role in stem cell homeostasis could provide
a powerful tool for a precise regulation of stem cell differentiation.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.06.007.
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